Sharpless lays out a scenario for achieving 15% payline for RPGs

NCAB approves ad hoc group to review TMIST, other detection trials impacted by COVID

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Budget increases in 2020 enabled NCI to boost funding for research project grants, pushing the payline up by two percentage points from last year’s level.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Alexandria Carolan
Alexandria Carolan
Reporter
Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.
Alexandria Carolan
Alexandria Carolan
Reporter
Paul Goldberg
Editor & Publisher

Login